WesBanco Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $657K | Sell |
4,191
-74
| -2% | -$11.1K | 0.02% | 449 |
|
|
2026
Q1 | $651K | Buy |
4,265
+915
| +27% | +$140K | 0.02% | 435 |
|
|
2025
Q4 | $462K | Sell |
3,350
-174
| -5% | -$22.8K | 0.01% | 508 |
|
|
2025
Q3 | $452K | Sell |
3,524
-140
| -4% | -$17.1K | 0.01% | 514 |
|
|
2025
Q2 | $443K | Hold |
3,664
| – | – | 0.01% | 496 |
|
|
2025
Q1 | $408K | Hold |
3,664
| – | – | 0.01% | 469 |
|
|
2024
Q4 | $357K | Sell |
3,664
-405
| -10% | -$43.2K | 0.01% | 494 |
|
|
2024
Q3 | $468K | Sell |
4,069
-30
| -0.7% | -$3.4K | 0.02% | 443 |
|
|
2024
Q2 | $436K | Sell |
4,099
-445
| -10% | -$44.7K | 0.02% | 436 |
|
|
2024
Q1 | $440K | Buy |
4,544
+652
| +17% | +$66.8K | 0.02% | 433 |
|
|
2023
Q4 | $393K | Sell |
3,892
-741
| -16% | -$71.5K | 0.02% | 287 |
|
|
2023
Q3 | $472K | Hold |
4,633
| – | – | 0.02% | 412 |
|
|
2023
Q2 | $467K | Sell |
4,633
-145
| -3% | -$14.5K | 0.02% | 421 |
|
|
2023
Q1 | $439K | Sell |
4,778
-226
| -5% | -$19.7K | 0.02% | 439 |
|
|
2022
Q4 | $454K | Buy |
5,004
+807
| +19% | +$68K | 0.02% | 424 |
|
|
2022
Q3 | $319K | Sell |
4,197
-951
| -18% | -$78.8K | 0.02% | 292 |
|
|
2022
Q2 | $435K | Sell |
5,148
-266
| -5% | -$23.3K | 0.02% | 418 |
|
|
2022
Q1 | $475K | Hold |
5,414
| – | – | 0.02% | 425 |
|
|
2021
Q4 | $473K | Sell |
5,414
-667
| -11% | -$55.4K | 0.02% | 430 |
|
|
2021
Q3 | $497K | Sell |
6,081
-716
| -11% | -$64.4K | 0.02% | 424 |
|
|
2021
Q2 | $620K | Buy |
6,797
+871
| +15% | +$77.6K | 0.02% | 387 |
|
|
2021
Q1 | $506K | Buy |
+5,926
| New | +$532K | 0.02% | 390 |
|
|
2020
Q3 | $609K | Sell |
7,003
-60
| -0.8% | -$5.2K | 0.03% | 335 |
|
|
2020
Q2 | $616K | Sell |
7,063
-65
| -0.9% | -$5.61K | 0.03% | 319 |
|
|
2020
Q1 | $588K | Sell |
7,128
-490
| -6% | -$43.7K | 0.03% | 305 |
|
|
2019
Q4 | $722K | Sell |
7,618
-65
| -0.8% | -$5.83K | 0.03% | 323 |
|
|
2019
Q3 | $668K | Sell |
7,683
-522
| -6% | -$46.9K | 0.03% | 325 |
|
|
2019
Q2 | $749K | Sell |
8,205
-857
| -9% | -$72.5K | 0.04% | 304 |
|
|
2019
Q1 | $780K | Buy |
9,062
+5,627
| +164% | +$452K | 0.04% | 296 |
|
|
2018
Q4 | $264K | Sell |
3,435
-30
| -0.9% | -$2.33K | 0.02% | 421 |
|
|
2018
Q3 | $267K | Sell |
3,465
-270
| -7% | -$20K | 0.01% | 471 |
|
|
2018
Q2 | $253K | Buy |
3,735
+728
| +24% | +$50.2K | 0.01% | 475 |
|
|
2018
Q1 | $217K | Hold |
3,007
| – | – | 0.01% | 490 |
|
|
2017
Q4 | $227K | Sell |
3,007
-69
| -2% | -$5.21K | 0.02% | 388 |
|
|
2017
Q3 | $236K | Sell |
3,076
-77
| -2% | -$5.82K | 0.01% | 463 |
|
|
2017
Q2 | $235K | Buy |
+3,153
| New | +$223K | 0.01% | 449 |
|
|
2017
Q1 | – | Sell |
-3,226
| Closed | -$210K | – | 523 |
|
|
2016
Q4 | $210K | Sell |
3,226
-97
| -3% | -$6.29K | 0.01% | 467 |
|
|
2016
Q3 | $235K | Hold |
3,323
| – | – | 0.01% | 438 |
|
|
2016
Q2 | $245K | Sell |
3,323
-553
| -14% | -$38.2K | 0.01% | 430 |
|
|
2016
Q1 | $252K | Sell |
3,876
-530
| -12% | -$36.1K | 0.02% | 414 |
|
|
2015
Q4 | $340K | Buy |
4,406
+770
| +21% | +$61.2K | 0.02% | 369 |
|
|
2015
Q3 | $299K | Hold |
3,636
| – | – | 0.02% | 381 |
|
|
2015
Q2 | $321K | Hold |
3,636
| – | – | 0.02% | 399 |
|
|
2015
Q1 | $322K | Sell |
3,636
-1,255
| -26% | -$111K | 0.02% | 401 |
|
|
2014
Q4 | $406K | Buy |
4,891
+223
| +5% | +$18.5K | 0.02% | 367 |
|
|
2014
Q3 | $394K | Hold |
4,668
| – | – | 0.02% | 377 |
|
|
2014
Q2 | $379K | Buy |
4,668
+697
| +18% | +$54.8K | 0.02% | 371 |
|
|
2014
Q1 | $303K | Sell |
3,971
-1,718
| -30% | -$125K | 0.02% | 423 |
|
|
2013
Q4 | $409K | Sell |
5,689
-228
| -4% | -$15.8K | 0.02% | 362 |
|
|
2013
Q3 | $407K | Sell |
5,917
-44
| -0.7% | -$2.91K | 0.03% | 367 |
|
|
2013
Q2 | $378K | Buy |
+5,961
| New | +$388K | 0.02% | 364 |
|
Other funds holding NVS
SI
CPC
OAM
KAS
WesBanco Bank's NVS Position: Q2 2026 in Review
WesBanco Bank reduced its Novartis (NVS) stake by 1.7% in Q2 2026, selling an estimated $11.1K and leaving 4,191 shares worth $657K. The position accounts for 0.02% of the portfolio, ranked #449.
WesBanco Bank first reported a position in NVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $780K in Q1 2019. 786 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- WesBanco Bank held 4,191 shares of Novartis worth $657K as of Q2 2026.
- WesBanco Bank sold 74 Novartis shares in Q2 2026, an estimated $11.1K.
- Novartis made up 0.02% of WesBanco Bank's portfolio in Q2 2026, its #449 holding.
- WesBanco Bank first reported a position in Novartis in Q2 2013 and has held it in 51 quarters since.
- WesBanco Bank's Novartis position peaked at $780K in Q1 2019.
- 786 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.